Symposium on Neuroimaging in Alcoholism

描述(由申请者提供)：第二次会议致力于酒精中毒的神经成像，这将是吸引成像研究人员转向酒精中毒研究的又一次开创性事件，希望促进对这种疾病的了解。在其他脑成像领域工作的资深研究人员以及那些已经在酒精中毒相关领域工作的人将被召集起来，分享酒精中毒的方法学应用，并促进跨模式的合作。将特别努力支持研究实习生、研究员和新研究人员的出席和参与。该方案将与2004年举行的极为成功的1Pst ICANA会议并行，在为期两天半的专题讨论会中列入国际发言者名单。预计观众将包括来自世界各地的150-200名研究人员。建议的会议日期为2008年1月18日至21日。 拟议的议程将包括6个主要议题和一个招贴会： 磁共振成像(MRI)和扩散张量成像(DTI) O功能磁共振成像(FMRI) O磁共振波谱(MRS) 用正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)进行神经受体成像 O动物的分子成像/基因表达、光学成像 O遗传学和临床前景 会议将包括全体会议和专门讨论各种成像方式(MRI-DTI、fMRI、MRS、PET-SPECT)的会议，以及与分子遗传学、动物和人类神经成像的联系，以及神经成像在酒精依赖治疗研究中的应用。

DESCRIPTION (provided by applicant): This second conference devoted to neuroimaging in alcoholism will be another seminal event in drawing imaging researchers toward research on alcoholism in hopes of advancing knowledge about this disorder. Established investigators who work in other areas of brain imaging as well as those already working in alcoholism-related areas will be convened to share methodological applications to alcoholism and foster collaboration across modalities. Special efforts will be made to support the attendance and participation of research trainees, fellows, and new investigators. The program will parallel the highly successful 1Pst ICANA conference held in 2004 by including an international roster of speakers in a two and a half-day symposium. The audience is expected to include 150-200 researchers from around the world. The proposed meeting dates are January 18-21-, 2008. The proposed agenda will include 6 main topics and a poster session: o Magnetic resonance imaging (MRI) & Diffusion tensor imaging (DTI) o Functional magnetic resonance imaging (fMRI) o Magnetic resonance spectroscopy (MRS) o Neuroreceptor imaging using Positron emission tomography (PET) & Single photon emission computed tomography (SPECT) o Molecular imaging/gene expression, Optical imaging in animals o Genetic and Clinical Perspectives The conference will include plenary presentations and sessions dedicated to each modality of imaging (MRI-DTI , fMRI, MRS, PET-SPECT), as well as links to molecular genetics, neuroimaging in animals and humans, and applications of neuroimaging to the study of the treatment of alcohol dependence.